Skip to main content
. Author manuscript; available in PMC: 2015 Feb 6.
Published in final edited form as: Am Econ Rev. 2011 May;101(3):377–381. doi: 10.1257/aer.101.3.377

Table 1.

All Plans Variance Improving
(1) Percentage Minimizing (2) Dollars Savings (3) Percentage Savings (4) Percentage Minimizing (5) Dollars Savings (6) Percentage Savings
All
12.17 296 31.01 26.89 237 23.42
Terciles of Age
1 11.30 298 31.94 25.67 238 24.16
2 12.38 296 30.96 27.43 234 23.20
3 12.87 295 30.07 27.58 238 22.88
Gender
F 12.73 295 30.63 27.40 236 23.20
M 11.21 299 31.66 25.98 237 23.82
Terciles of 2005 Expenditures
1 10.65 217 34.26 27.33 159 25.14
2 13.04 264 30.75 27.31 208 23.27
3 12.84 424 27.68 25.55 358 21.84
Terciles of Percent Chronic Drugs
1 10.46 274 33.02 25.83 214 24.81
2 12.70 326 30.05 27.12 264 22.81
3 13.30 289 30.01 27.69 231 22.69

Notes: The first three columns give the percentage of patients choosing the cost minimizing plan, the average savings from switching to the cost minimizing plan, and the average savings as a percentage of realized out of pocket costs from switching to the cost minimizing plan. Columns (4)-(6) give the same numbers, but considering only plans which are variance-improving (i.e. whose variance is at least as small as the chosen plan). The % of acute drugs is computed as the proportion of claims in 2005 for a drug which also appears in the data in 2006.